MJNA - Medical Marijuana, Inc.
| Previous Close | 0.0263 |
| Open | 0.0263 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0260 - 0.0274 |
| 52 Week Range | 0.0200 - 0.1100 |
| Volume | 2,939,091 |
| Avg. Volume | 5,837,096 |
| Market Cap | 225.593M |
| Beta (3Y Monthly) | -2.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0140 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Hemp for Humanity Educational Event Tour Throughout Japan
SAN DIEGO , Oct. 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc . ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's ...
- PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Hosts Panel at Lide Futuro Debate in São Paulo
SAN DIEGO, Oct. 15, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinz will be hosting a featured panel at the Lide Futuro Debate entitled, "Cannabusiness: National Potential and Business Segments," on Oct. 18 at the Museum of Image and Sound (MIS) in São Paulo, Brazil. According to a survey by New Frontier Data, Brazil's cannabis market could be worth around $4.4 billion by 2022, equivalent to 6.3 percent of the total revenue of the Brazilian pharmaceutical industry. If projections are correct, Brazil could become a more prominent leader in the Latin American cannabis market, surpassing the cannabis sales revenue of both Mexico and Chile.
- PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of New Website and Back Office for Japan Division
SAN DIEGO, Oct. 10, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a new website and back office available in Japanese catered to servicing the expansion into Japan and Asia. Kannaway®'s new Japanese language website is designed to fit the specific needs of Japanese consumers and business owners. The site will feature the latest news, announcements and promotional offers from Kannaway® in a streamlined and easy-to-navigate design.
- PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® and Company CEO Honored in 11th Annual Golden Bridge Awards
SAN DIEGO, Oct. 8, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has earned two prestigious Golden Bridge Awards® -- including a Silver Award for Company of the Year in the Healthcare Products and Services category and the Company's CEO Blake Schroeder earned a Gold Award for International Executive of the Year in the Healthcare Products and Services category.
- PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour
SAN DIEGO , Oct. 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc . ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's ...
- PR Newswire
Medical Marijuana, Inc. CEO to Speak at Hemp for the Future Event in Reykjavík, Iceland
SAN DIEGO, Oct. 1, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company's Chief Executive Officer Dr. Stuart Titus will be presenting at the Hemp for the Future educational event in Reykjavík, Iceland, on Oct. 1-2. Medical doctors, scientists, hemp farmers, and patients will share their knowledge on the current industry landscape and future of hemp. "Medical Marijuana, Inc. is one of the hemp industry's leaders on the forefront of developing new international markets, and I am excited to have the opportunity to help pioneer educational efforts in a promising new market such as Iceland," Titus said.
- PR Newswire
Medical Marijuana, Inc. Reaches One-Year Milestone in High-Level CBD Hemp Oil Stability Study
SAN DIEGO , Sept. 26, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...
- PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Presents at MJBizDaily Latin American Cannabis Symposium
SAN DIEGO, Sept. 24, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinz will be a featured speaker at the MJBizDaily Latin American Cannabis Symposium in Bogotá, Columbia, on Sept. 30 – Oct. 1. Caroline Heinz will speak on Oct. 1 at 9:50 a.m. on a panel entitled "Potential Powerhouse: Where Brazil Stands" discussing the potential for upcoming reform in which domestic cultivation would be regulated and cannabis products could be registered without finished clinical trials for the first time in Brazil. The panel will also discuss how to prepare to cultivate cannabis in Brazil and what significant new business opportunities this reform could create for the entire Latin American cannabis industry.
- PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Super Academy Event and Product Launch in Amsterdam
SAN DIEGO, Sept. 19, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® is hosting a Super Academy event in Amsterdam on Sept. 27-29. The event will give Kannaway®'s European Brand Ambassadors the opportunity to network with top Kannaway® Europe leaders, the Company's global executive team and fellow business owners. The Brightfield Group predicts that "impending regulatory changes" will drive Europe's CBD market from $318 million last year to $416 million in 2019, and also projects that market will surge 400% to $1.7 billion by 2025.
- Market Exclusive
AXIM to Launch CBD Chewing Gum to Treat Chemotherapy Symptoms
Medical Marijuana (OTC: MJNA) announced that its major investment company AXIM Biotechnologies (OTCQB: AXIM) is making its cannabinoid-based chewing gum to treat chemotherapy-related symptoms. The chewing gum with dronabinol, a synthetic form of tetrahydrocannabinol (THC), is being manufactured through AXIM's contract manufacturer Eurofins Amatsigroup in Belgium. It will be used in AXIM's upcoming clinical studies on cannabis as a treatment […]The post AXIM to Launch CBD Chewing Gum to Treat Chemotherapy Symptoms appeared first on Market Exclusive.
- PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Signs Agreement with Online Marketplace Dr. Cannabis
SAN DIEGO, Sept. 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary HempMeds® Brasil, the first Anvisa-authorized company to import cannabidiol (CBD)-based medicines in the country, has signed a partnership agreement for Dr. Cannabis, an online marketplace that facilitates patient access to medical cannabis, to become the exclusive Brazilian reseller of the Company's CBD products. Since 2014, almost 10,000 authorizations have been granted to individual patients, allowing them to import medical cannabis on a case-by-case basis, each for a period of up to one year.
- PR Newswire
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies
SAN DIEGO , Sept. 12, 2019 /PRNewswire/ -- Medical Marijuana, Inc . (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...
- PR Newswire
HempMeds®, Subsidiary of Medical Marijuana, Inc., Announces Presence at Natural Products Expo East
SAN DIEGO, Sept. 10, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® will be attending and exhibiting at Natural Products Expo East in Baltimore, Maryland, on Sept. 11-14. According to a 2019 report by Natural Food Merchandiser magazine, the Natural Products Market produced over $158 million in sales in 2018 and is projected to grow by 49 percent in 2019. At the conference, HempMeds® will exhibit its well-trusted hemp-derived CBD lifestyle brands such as its Real Scientific Hemp Oil™ and Dixie Botanicals® as well as the Company's Personal Care Line of hair and skincare products, Everyday Wellness Line of functional products and brand new pet products.
- PR Newswire
Medical Marijuana, Inc. and Subsidiary Dixie Botanicals® Secure National News Coverage in Leading Financial Publication Benzinga
SAN DIEGO , Sept. 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...
- Benzinga
The Week In Cannabis: Moves From The DEA, FDA, USDA; New York Fashion Week; And Quarterly Reports
A series of earnings reports from big companies including Slang Worldwide Inc (OTC: SLGWF) and TILT Holdings Inc (OTC: SVVTF) provided evidence that “the slow rollout of Massachusetts' recreational licenses has finally hit the earnings of cannabis companies who were slow to recognize the effects,” Green Market Report CEO Debra Borchardt told Benzinga. In other news, we found out that a weed-themed show is hitting the runway at the New York Fashion Week, the product of a collaboration between bold fashion designer Korto Momolu —featured on the show "Project Runway" —and Women Grow, the largest networking organization for women in the cannabis and hemp industries. "To sum it up in one phrase: it's 'for women, by women,'" Momolu told Benzinga.
- Market Exclusive
Cannabis Stock News Daily Roundup August 27
iAnthus Capital Holdings (CSE: IAN) (OTCQX: ITHUF) reported its financial results for the fiscal second quarter ended June 30. Revenue for the quarter was $19.20 million, up from $256,000 for the same period of last year. The company posted a loss of $9.29 million, or $0.06 loss per share, versus a loss of $35.44 million, or […]The post Cannabis Stock News Daily Roundup August 27 appeared first on Market Exclusive.
- PR Newswire
HempMeds®, Subsidiary of Medical Marijuana, Inc., Releases Hemp for Pets Product Line in Celebration on National Dog Day
SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has released its Hemp for Pets pet cannabidiol (CBD) product line in celebration of National Dog Day. Hemp for Pets by HempMeds® was created to help improve the lives of all pets, from nose to tail. The Company, a proud member of the National Pet Supplement Council (NPSC), aims to improve the lives of pets and people naturally with a commitment to ethically-sourced hemp CBD extract and natural ingredients, dedicated scientific expertise and innovation backed by the strictest efficacy testing.
- PR Newswire
Medical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics
SAN DIEGO, Aug. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that equity research firm Avise Analytics, Ltd. ("Avise Analytics") ranked the Company as one of the Top 5 Companies in the Hemp-Based Cannabidiol (CBD) Market. "It is an honor to once again be recognized as a leader in the cannabis industry and specifically the CBD market," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. Avise Analytics, founded in 2012, is an international provider of high-quality research and offers a comprehensive range of customized equity research outsourcing services, investment, financial and credit research outsourcing solutions.
- Benzinga
Everyday CBD: Sun, Sand, And SeaBD
If you’ve been paying attention to the sunscreen scene of late, you’ve probably seen how tropical destinations like Hawaii and Key West are banning common sunscreen chemicals oxybenzone and octinoxate since they damage delicate marine ecosystems. According to Punjabi, the benefits center around the anti-inflammatory properties of CBD, which can help “almost every skin condition you can think of—from eczema to acne.” Since the skin doesn’t absorb CBD as well as inhaling or ingesting it—which allows it to enter the bloodstream—CBD-based skincare products are a great “gateway” product for consumers new to the hemp industry.
- PR Newswire
Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as Stevie® Award Winners in 2019 International Business Awards®
SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company was named the winner of a Bronze Stevie® Award in the Most Innovative Company of the Year – Up to 100 Employees category in The 16th Annual International Business Awards. "Medical Marijuana, Inc. has been devoted to innovating all aspects of the CBD industry since new management took control in March 2011," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
- PR Newswire
Medical Marijuana, Inc. Reports $20.7 Million in Revenue in Q2 2019, Up 30% Year-Over-Year in Financial Results
SAN DIEGO , Aug. 15, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...
- GlobeNewswire
Medical Marijuana, Inc. Announces Second Quarter Filing Date and Schedules Investor Conference Call for August 15, 2019
Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that the Company will file its second quarter financial and operational results on August 14 and will host an investor conference call at 4:30 PM ET on Thursday, Aug. 15, to discuss earnings for the quarter ending June 30, 2019. Medical Marijuana, Inc. CEO Dr. Stuart Titus and COO Blake Schroeder will provide updates on the financial and operational performance of the Company in the second quarter of 2019, share recent research and development progress, and discuss where the company is headed for the remainder of the year and in the future.
- PR Newswire
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies
SAN DIEGO , Aug. 7, 2019 /PRNewswire/ -- Medical Marijuana, Inc . (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived ...
- Benzinga
CBD And Chemotherapy-Induced Peripheral Neuropathy: What Science Tells Us
A recent study revealed research findings around chemotherapy-induced peripheral neuropathy, or CIPN, and the potential for CBD as a treatment. The study, conducted by Kannalife, a company in the Medical Marijuana Inc (OTC: MJNA) portfolio, and published in the Journal of Molecular Neuroscience, showed that both CBD and the company's proprietary CBD-like molecule, KLS-13019, had protective action on the mitochondrial exchanger known to increase calcium levels — and therefore neuropathic pain — in patients taking the chemotherapy drug paclitaxel. It's actually a greater difference in potency," said Dr. Doug Brenneman, Kannalife's lead scientist.
- PR Newswire
Medical Marijuana, Inc. Subsidiaries HempMeds®, HempMeds® Mexico and HempMeds® Brasil Announce July 2019 as the Largest Sales Bookings Month in Company History
SAN DIEGO , Aug. 6, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...